Puerto Rico’s Molecular Sciences Research Center Signals Resurgent Industry
Executive Summary
The five-year old center is to include the island’s first preclinical facility. Researchers there are working on an HIV vaccine with support from Amgen, Lilly and the US National Institutes of Health.
You may also be interested in...
Puerto Rico Bolsters Its Life-Sciences Hub With R&D, Start-Up Initiatives
In the past year, Puerto Rico formed a consortium of clinical trial sites, launched a funding program for entrepreneurs and created a technology transfer office – all achievements touted at the Biolatam biotech conference in San Juan.
Puerto Rico Bolsters Its Biopharma Hub With R&D, Start-Up Initiatives
In the past year, Puerto Rico formed a consortium of clinical trial sites, launched a funding program for entrepreneurs and created a technology transfer office – all achievements touted at the Biolatam biotech conference in San Juan.
Puerto Rico Bolsters Its Biopharma Hub With R&D, Start-Up Initiatives
In the past year, Puerto Rico formed a consortium of clinical trial sites, launched a funding program for entrepreneurs and created a technology transfer office – all achievements touted at the Biolatam biotech conference in San Juan.